6915-1 Alcohol Use Disorder Training for Inspira Health Residency Program-Recording

Video Transcription

Video Summary

In the video transcript, Dr. Benjamin Shreve, a double board-certified psychiatrist, presents on substance use disorders, specifically alcohol use disorder treatment. He discusses various pharmacotherapies, including disulfiram, naltrexone, acamprosate, gabapentin, topiramate, baclofen, and prazosin. Dr. Shreve provides insights on the timing of initiating treatments post-alcohol withdrawal and addresses protocols like the Clinical Institute Withdrawal Assessment for Alcohol (CIWA). He suggests a symptom-based approach over protocolized treatment and emphasizes the importance of closely monitoring patient symptoms and management. Dr. Shreve also highlights emerging therapies like psychedelics and GLP-1 receptor agonists and offers resources for treatment options. Throughout the discussion, he stresses the need for individualized care, considering patient goals and motivations.

Keywords

alcohol use disorder treatment

pharmacotherapies

Clinical Institute Withdrawal Assessment for Alcohol

symptom-based approach

emerging therapies

individualized care

Dr. Benjamin Shreve

substance use disorders

patient goals